<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04014218</url>
  </required_header>
  <id_info>
    <org_study_id>SS2019</org_study_id>
    <nct_id>NCT04014218</nct_id>
  </id_info>
  <brief_title>Effect of Inhalation Sedation Compared With Propofol on the Sepsis-related Acute Respiratory Distress Syndrome Course</brief_title>
  <official_title>Effect of Inhalation Sedation With Sevoflurane Compared With Propofol on the Sepsis-related Acute Respiratory Distress Syndrome (ARDS) Course.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>I.M. Sechenov First Moscow State Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation of effect of inhalation sedation by administration of Sevoflurane compared with
      Propofol on the moderate acute respiratory distress syndrome course in mechanically
      ventilated patients with sepsis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2019</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>opaque envelopes</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>28 days after ICU admission</time_frame>
    <description>28 days and in-hospital mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ICU Length of stay (LOS)</measure>
    <time_frame>45 days after ICU admission</time_frame>
    <description>Length of stay in ICU</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of mechanical ventilation (LMV)</measure>
    <time_frame>45 days after ICU admission</time_frame>
    <description>Length of mechanical ventilation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>P/F Ratio</measure>
    <time_frame>45 days after ICU admission</time_frame>
    <description>minimal pO2/FiO2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium</measure>
    <time_frame>5 days after ICU admission</time_frame>
    <description>onset and duration of delirium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACCE</measure>
    <time_frame>28 days after ICU admission</time_frame>
    <description>Major Adverse Cardiac and Cerebrovascular Event</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>event of RRT</measure>
    <time_frame>28 days after ICU admission</time_frame>
    <description>event of Renal Replacement Therapy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>ARDS</condition>
  <arm_group>
    <arm_group_label>Inhalation sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhalation Sedation</intervention_name>
    <description>Inhalation Sedation by Administration of Sevoflurane</description>
    <arm_group_label>Inhalation sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous Sedation</intervention_name>
    <description>Intravenous Sedation by Administration of Propofol</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  sepsis

          -  ARDS

          -  P/F Ratio 100-250

          -  start of mechanical ventilation

        Exclusion Criteria:

          -  pregnancy

          -  concomitant oncological disease

          -  prior psychological impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valery V Likhvantsev,</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moscow Regional Clinical and Research Institute, Department of Intensive Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valery V Likhvantsev,</last_name>
    <phone>+7 (903) 623-59-82</phone>
    <email>lik0704@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</name>
      <address>
        <city>Moscow</city>
        <zip>129110</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valery V Likhvantsev, Professor</last_name>
      <phone>+7 (903) 623-59-82</phone>
      <email>lik0704@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 2, 2019</study_first_submitted>
  <study_first_submitted_qc>July 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 10, 2019</study_first_posted>
  <last_update_submitted>July 9, 2019</last_update_submitted>
  <last_update_submitted_qc>July 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</investigator_affiliation>
    <investigator_full_name>Valery V. Likhvantsev, Professor</investigator_full_name>
    <investigator_title>Professor, Head of Intensive Care Department Moscow Regional Clinical and Research Institute</investigator_title>
  </responsible_party>
  <keyword>sedation</keyword>
  <keyword>ARDS</keyword>
  <keyword>sepsis</keyword>
  <keyword>outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

